2017
DOI: 10.1007/7355_2017_17
|View full text |Cite
|
Sign up to set email alerts
|

Quorum Sensing Inhibitors as Pathoblockers for Pseudomonas aeruginosa Infections: A New Concept in Anti-Infective Drug Discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 93 publications
0
16
0
1
Order By: Relevance
“…In contrast to the conventional microbicidal antibiotics, antivirulence agents curb the pathogenicity/virulence without necessarily displaying any notable growth-inhibitory effect. Such “pathoblockers” are likely to emerge as a new category of “tailored spectrum” superior therapeutics [3941]. Based on this logic and early enthusiasm surrounding QS inhibitors, latter were viewed as “evolution-proof drugs” [42].…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to the conventional microbicidal antibiotics, antivirulence agents curb the pathogenicity/virulence without necessarily displaying any notable growth-inhibitory effect. Such “pathoblockers” are likely to emerge as a new category of “tailored spectrum” superior therapeutics [3941]. Based on this logic and early enthusiasm surrounding QS inhibitors, latter were viewed as “evolution-proof drugs” [42].…”
Section: Discussionmentioning
confidence: 99%
“…Carbapenem-resistant Pseudomonas aeruginosa is one of the most critical antibiotic-resistant bacteria as recently classified by the World Health Organization 1 , which is the reason why current anti-infective research is dedicated to the development of new treatment options against this pathogen 2 , 3 . Infections with P. aeruginosa lead to severe complications in chronic lung diseases like cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and non-CF bronchiectasis (NCFB), often leading to significantly increased morbidity and mortality 4 , 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Ability of GLE to interfere with bacterial QS is an important observation, as QS in recent years has emerged as a potential target for novel anti-pathogenic agents ( Fong et al , 2018). These ‘pathoblockers’ may attenuate virulence of the target pathogens without necessarily killing them ( Kamal et al , 2017).…”
Section: Resultsmentioning
confidence: 99%